학술논문

AML-256 A Phase 1 Study of Gilteritinib in Combination With Induction and Consolidation Chemotherapy in Patients With Newly Diagnosed Acute Myeloid Leukemia: Final Study Results
Document Type
Article
Source
In Clinical Lymphoma, Myeloma and Leukemia October 2022 22 Supplement 2:S230-S230
Subject
Language
ISSN
2152-2650